|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 2 August 2021, 13:51. The announcement is marked as price sensitive, and is 3 page(s) in length and 309.97kb in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.103% short sold according to ASIC data. It was ranked the 443rd most shorted stock on the ASX. It is now ranked as the 425th most shorted stock on the ASX with 0.099% of total shares short sold as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| CelGro Facilitates Lymphatic Vessel Regeneration Updated | 2 August 2021, 13:51 |
| CelGro Facilitates Lymphatic Vessel Regeneration | 2 August 2021, 9:20 |
| Appendix 4C - Quarterly | 28 July 2021, 9:29 |
| Orthocell Appoints Exclusive Distributor in Australia | 13 July 2021, 10:07 |
You must be logged in to post a reply.
Orthocell 